Non-value-added activities in Johnson & Johnson pharmaceuticals

Unnecessary testing and storage of raw materials and finished products

According to the Johnson & Johnson website, its products' safety is as safe as the raw materials they use to make them. To achieve these goals, the company passes its raw materials and finished products through vigorous testing, which results in prolonged storage before the raw materials can be used or before the finished goods can be released to the market (jnj.com, 2022). These activities affect the company since the stored raw materials and finished goods occupy space and waste much time through the tests.

Ways in which Johnson & Johnson can eliminate unnecessary testing and storage of raw materials and finished products.

Health products are susceptible, and providing products that meet the regulatory requirements is essential to Johnson & Johnson's business. However, the company passes its raw materials in a series of unnecessary tests and stores the raw materials and its products for extended periods. The company can reduce unnecessary storage by adopting a more advanced testing process which will fast-track the testing process and reduce the excessive storage period.

Question:

This a little off topic, but you brought up Johnson & Johnson. What is your opinion on the profits that the vaccine makers such as Johnson & Johnson should yield? What is an acceptable level? You might remember the Pharma Bro story where Martin Shkreli raised the price of an HIV drug by 5000% the day he took control. But on the other hand,the drug companies should be rewarded for their efforts. Should their drugs be made available for other companies to manufacture ignoring patent laws for the benefit of humanity? What are your thoughts?